← Back to Search

Gambling and Smoking Treatment for Gambling Addiction

N/A
Waitlist Available
Led By Matthew T Keough, PhD
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up percentage of people at baseline (t0),immediately following the 8-week treatment (t1), and at follow-up (i.e., 24 weeks from baseline, 16 weeks from end of treatment, t2).
Awards & highlights

Study Summary

This study is evaluating whether a treatment that combines problem gambling and tobacco smoking can be effective.

Eligible Conditions
  • Gambling Addiction

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~percentage of people at baseline (t0),immediately following the 8-week treatment (t1), and at follow-up (i.e., 24 weeks from baseline, 16 weeks from end of treatment, t2).
This trial's timeline: 3 weeks for screening, Varies for treatment, and percentage of people at baseline (t0),immediately following the 8-week treatment (t1), and at follow-up (i.e., 24 weeks from baseline, 16 weeks from end of treatment, t2). for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in money spent gambling
Change in number of days gambled
Change in time spent gambling
Secondary outcome measures
Cigarette use
Gambling symptom assessment
Nicotine dependence symptoms
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Gambling and Smoking TreatmentExperimental Treatment1 Intervention
Participants in this arm will be given access to the online integrated treatment for gambling and smoking.
Group II: Gambling Only TreatmentActive Control1 Intervention
Participants in this arm will be given access to the online gambling only treatment.

Find a Location

Who is running the clinical trial?

University of ManitobaLead Sponsor
595 Previous Clinical Trials
199,222 Total Patients Enrolled
Sherry H Stewart, PhDStudy ChairDalhousie University
Matthew T Keough, PhDPrincipal InvestigatorUniversity of Manitoba

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~46 spots leftby Apr 2025